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Abstract
Introduction 
Childhood obesity is associated with an increased risk for type 2 diabetes. Early identification of adolescents at risk for 
impaired fasting glucose may lead to earlier and more comprehensive evaluation and intervention. Because 
widespread glucose testing of adolescents is not recommended, community-based tools are needed to identify those 
who could benefit from further testing. One such tool, developed for adults, was the Tool for Assessing Glucose 
ImpairmenT (TAG-IT). Our objective was to validate whether a similar tool could be useful for community-based 
screening of glucose impairment risk among adolescents.
Methods 
Our study sample consisted of 3,050 adolescents aged 12 to18 years who had participated in the 1999-2008 National 
Health and Nutrition Examination Survey (NHANES). Half of participants were female and 40% were nonwhite. 
NHANES measured fasting glucose and height, weight, and resting heart rate. We used Pearson correlations and 
regression analysis to determine key variables for predicting glucose impairment. From these measurements, we 
created a composite TAG-IT score for adolescents called TAG-IT-A. We then applied the TAG-IT-A model to 1988-
1994 NHANES data, using linear regression analysis and receiver operating characteristic analysis to determine how 
well the TAG-IT-A score predicted a fasting glucose at or above 100 mg/dL.
Results 
We determined that age, sex, body mass index, and resting heart rate were important predictors of impaired fasting 
glucose and that TAG-IT-A was a better predictor of impaired fasting glucose than body mass index alone (area under 
the curve, 0.61, P < .001 vs 0.55, P = .10, respectively). A TAG-IT-A score of 3 or higher correctly identified 50% of 
adolescents with impaired fasting glucose, while a score of 5 or higher correctly identified 76% .
Conclusion 
The TAG-IT-A score is a simple screening tool that clinicians and public health professionals could use to easily 
identify adolescents who may have impaired fasting glucose and need a more comprehensive evaluation.
Introduction
Obesity rates have tripled in the past 20 years among children and adolescents, leading to an obesity epidemic in this 
population (1,2). Concurrent with this increase in obesity has been an increase in the incidence of type 2 diabetes in 
this same population (3). An estimated 1 in 3 children born in the United States in 2000 will develop type 2 diabetes at 
some point in their lifetime (4).
Because few children have impaired fasting glucose, widespread use of glucose screening in this population is not 
recommended. In addition, many adolescents seek health care infrequently and only for acute problems and thus may 
go years without contact with a health care provider. New tools are needed for community-based screening to identify 
those at increased risk of glucose impairment and in need of further evaluation or interventions.
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In adults, the Tool for Assessing Glucose ImpairmenT (TAG-IT) was developed for use in the community to assess risk 
of glucose impairment (5). Compared with using body mass index (BMI) alone, TAG-IT was much better at predicting 
glucose impairment. Furthermore, a TAG-IT score of 5 or higher correctly identified those with glucose impairment 
87% of the time (5). In addition to TAG-IT, He et al (6) developed the Abnormal Glucose Risk Asessment-6 (AGRA-6), 
which includes 6 models for assessing risk for abnormal glucose levels. These models examine different measures of 
abnormal glucose, such as impaired fasting glucose, impaired glucose tolerance, undiagnosed diabetes, and all other 
types of glucose impairment. The area under the curve for all 6 models was 0.72 to 0.80. The authors also reported 
that the AGRA-6 models accurately predicted about 70% of those with abnormal blood glucose (6).
Although both TAG-IT and AGRA-6 are valid community screening tools to assess glucose impairment risk in adults 
(5,6), to our knowledge, a similar glucose impairment screening tool for adolescents (age 12-18 y) does not exist. 
Adolescents are growing and transitioning through puberty, which may affect body composition, physical activity 
levels, resting heart rate, and insulin resistance. Therefore, methods for predicting insulin resistance or glucose 
impairment in adults may not be effective in adolescents.
Our objective was to develop and validate a community-based screening tool specifically for adolescents. The tool is 
based on TAG-IT, the adult screening tool, and is called Tool for Assessing Glucose ImpairmenT among Adolescents 
(TAG-IT-A). We hypothesized that the TAG-IT-A tool would effectively predict risk of impaired fasting glucose levels in 
adolescents.
Methods
The Centers for Disease Control and Prevention (CDC) conducts the National Health and Nutrition Examination 
Survey (NHANES) annually. NHANES uses complex probability sampling with a cluster sample design to assess the 
health and nutritional status of adults and children in the United States. For our study, we used multiple NHANES 
data sets. We used the 1999-2008 NHANES data to develop TAG-IT-A because NHANES oversampled adolescents and 
racial/ethnic minorities during these years to provide more precise population estimates. Furthermore, given the rise 
in the prevalence of type 2 diabetes, there were more adolescents with elevated glucose levels in later years (1999-
2008) compared with earlier NHANES data sets (1988-1994). After using the 1999-2008 NHANES data to develop 
TAG-IT-A, we used NHANES III (1988-1994) data to validate the TAG-IT-A score in a manner similar to that 
described by Koopman (5). The NHANES protocols were approved by CDC’s institutional review board. We obtained 
written informed consent from legal guardians and assent from minors.
TAG-IT-A development sample
To develop the TAG-IT-A score, we used data from adolescents aged 12 to 18 who participated in the fasting subsample 
of the NHANES 1999-2008 survey. We excluded participants who did not have a fasting blood sample, were currently 
taking diabetes medication, or had incomplete data on key variables used in the data analysis.
TAG-IT-A variables
The purpose of the screening tool is to use demographic and noninvasive clinical variables to identify adolescents with 
a fasting blood glucose at or greater than 100 mg/dL, defined by the American Diabetes Association as impaired (7). 
Key variables used in the development of the screening tool for adolescents were modeled after those used to develop 
the adult screening tool, TAG-IT (5). The variables considered for inclusion in the adolescent screening tool were age, 
race, sex, body mass index (BMI), resting heart rate, hypertension diagnosis (measured resting blood pressure or 
physician diagnosis), and fasting blood glucose. The only variable investigated in the adult tool that was not explored 
with the adolescent screening tool was a family history of diabetes, because NHANES did not ask adolescents about 
this.
Age, race, and sex were all self-reported, and race was categorized as non-Hispanic white, non-Hispanic blacks, 
Hispanic, or other (Asian and American Indian). Age was then divided into 2 groups, 12 to 14 and 15 to 18. BMI was 
calculated from height and weight, which was measured by trained technicians who used standard NHANES methods 
(8). We used BMI values from the CDC growth charts for US children to categorize each adolescent as normal weight 
(≤ 84th percentile), overweight (85th-94th percentile), or obese (≥95th percentile) (9). Resting heart rate and blood 
pressure were measured by using standard NHANES procedures (10). Resting heart rate was grouped into 10-beat 
intervals (eg, <60, 60-69, 70-79.). We classified hypertension as a resting blood pressure at or greater than the 95th 
percentile adjusted for age, sex, and height or participant self-report of a physician diagnosis of hypertension (11).
TAG-IT-A validation sample
To validate TAG-IT-A we used data on adolescents who participated in the fasting glucose subsample of NHANES III 
(1988-1994). We excluded adolescents who did not have a fasting blood sample, were currently taking diabetes 
medication, or had incomplete data on key variables used in the data analysis. The same variables used to develop the 
TAG-IT-A tool were used in the validation sample. Age, race, sex, and BMI were used as the predictive variables of the 
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population from the NHANES III database, and fasting glucose was used as the outcome variable to validate the TAG-
IT-A score.
Statistical analysis
In all analyses, we used NHANES weights to accommodate the complex sampling design of NHANES. The weights 
account for geographic probability sampling methods and oversampling of specific groups, such as minorities and 
adolescents, and are designed to ensure that the weighted findings are representative of all US adolescents.
We used scatter plots to examine the relationship between fasting glucose levels and age, race, sex, BMI, resting heart 
rate, and hypertension. Pearson product moment and point biserial correlations were used to examine the 
relationships among these key variables. Following the approach taken by Koopman et al (5) in adults, we used 
multiple regression analysis to identify the variables associated with a fasting glucose of 100 mg/dL or higher. 
Potential independent variables that we entered into the regression model were age, race, sex, BMI, resting heart rate, 
and hypertension diagnosis; fasting glucose was the dependent variable entered. If the P value was less than or equal 
to .05, the variable was associated with an impaired fasting glucose level. Once we identified significant variables, we 
used logistic regression analysis to examine the relationship of these variables to fasting glucose levels. We also used 
the logistic regression model to generate weighted scores for each key factor that the TAG-IT-A score comprised. The 
method for developing the weighted scores was modeled after the widely used Charlson Comorbidity Index (12), in 
which odds ratios (ORs) from 1.0 to 1.19 were assigned 0 points, ORs from 1.2 to 1.49 were assigned 1 point, ORs from 
1.5 to 2.49 were assigned 2 points, and so on. After the TAG-IT-A scoring system was created, receiver operating 
characteristic (ROC) curves were constructed to examine the area under the curve for TAG-IT-A’s ability to predict 
fasting glucose impairment in the NHANES III sample. For comparison, an ROC curve was also generated to examine 
the ability of BMI alone to predict fasting glucose impairment in the NHANES III sample. We used SAS-callable 
SUDAAN version 9 (RTI International, Research Triangle Park, North Carolina) to conduct all data analysis except for 
ROC generation, for which we used SAS version 9 (SAS Institute, Inc, Cary, North Carolina). We set statistical 
significance at P <.05.
Results
A total of 3,050 adolescents from NHANES 1999-2008 with complete data were included in the analysis to develop 
TAG-IT-A. Most participants were white (63%); 51% were male, 32% were either overweight or obese, and 16% had a 
fasting glucose value of 100 mg/dL or higher (Table 1). A total of 2,564 adolescents from the NHANES III sample were 
analyzed for validation of TAG-IT-A. The sample was primarily white (66%); 51% were male, 27% were either 
overweight or obese, and 11% had a fasting glucose value of 100 mg/dL or greater.
Correlations among the variables examined for the TAG-IT-A score were low, but we found a positive and significant 
relationship between fasting glucose, age, BMI, and resting heart rate (Table 2). Age was positively related to BMI but 
negatively related to resting heart rate. Sex was positively related to BMI and resting heart rate. Finally, BMI was 
positively related to hypertension status.
The variables related to impaired fasting glucose included being aged 12 to 14, male, obese, and having a resting heart 
rate of 70 beats per minutes or higher (Table 3). The odds of having an impaired fasting glucose level for each of these 
variables were at least 1.66 times as great as those of the reference group.
Twenty-nine percent of the adolescents in NHANES III had a TAG-IT-A score of 3 or higher, and 14% had a TAG-IT-A 
score of 7 or higher (Table 4). As scores increased from 3 or higher, the sensitivity improved; a TAG-IT-A score of 5 
correctly identified 76% of participants with impaired fasting glucose .
The area under the curve was 0.61 for the TAG-IT-A tool compared with 0.55 for BMI alone, which suggests that the 
TAG-IT-A tool is modestly more useful than BMI alone in identifying adolescents who may need additional evaluation 
for impaired fasting glucose (Figure).
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Figure. Receiver operating characteristic (ROC) curves using Tool for Assessing Glucose ImpairmenT for Adolescents 
(TAG-IT-A) and body mass index (BMI) alone with NHANES III data to predict glucose levels ≥100 mg/dL among 
adolescents. The TAG-IT-A model is a tool developed for use in the community to assess risk of glucose impairment in 
adolescents. The area under the curve for TAG-IT-A is 0.61 (P < .001) and for BMI only is 0.55 (P = .10). 
Abbreviations: ROC, receiver operating characteristic; TAG-IT-A, Tool for Assessing Glucose ImpairmenT among 
Adolescents; BMI, body mass index; NHANES III, National Health and Nutrition Examination Survey, 1999-1994. [A 
tabular version of this figure is also available.]
Discussion
We found that fasting glucose levels were positively related to BMI. Eisenmann et al (13) reported that various markers 
for insulin sensitivity, including fasting glucose levels, were higher among obese children than among normal-weight 
children. We have reported similar findings in our patient population (14). In addition, we found that BMI was 
positively correlated with hypertension status. Obese girls were 6 times more likely to have hypertension than normal-
weight girls (15). Falaschetti et al (16) reported that a 1 kg/m2 increase in BMI in children was associated with a 1.4 
mm Hg higher systolic blood pressure. To our knowledge, the positive relationship between fasting glucose and resting 
heart rate has not been examined in the adolescent population. Among adults, elevated resting heart rates are linked to 
higher all-cause and cardiovascular disease mortality (17) and higher odds for elevated blood pressure (systolic and 
diastolic), abnormal fasting glucose, hypertriglyceridemia, and obesity (18). Although only 4% of adolescents in our 
sample had a heart rate higher than 100 beats per minute, measuring and tracking resting heart rate may be important 
because those with a resting heart rate above 70 beats per minute were twice as likely to have impaired fasting glucose.
Age, sex, BMI, and resting heart rate were the only predictors included in the final model of the TAG-IT-A score. These 
variables are different from what was included in the adult TAG-IT score. Koopman et al (5) found that, in addition to 
these 4 predictors, it was necessary to include family history of diabetes and history of hypertension in the model. Our 
analysis was limited by the lack of available data on family history of diabetes in the NHANES data sets. Including 
family history of diabetes in the model may have improved its predictive value as measured by ROC analysis (19). 
Others have developed screening tools for assessing abnormal blood glucose values in adults and reported that in 
addition to age, BMI, and race, hypertension medication use was also an important predictor (6). A group from 
Denmark reported that identification of adolescents at risk for developing type 2 diabetes was improved when blood 
glucose values and triglyceride concentrations were added to systolic blood pressure and parental diabetes (20).
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We hypothesized that the TAG-IT-A score would be an effective predictor of impaired fasting glucose among 
adolescents; however, the TAG-IT-A tool was only modestly better than BMI alone (0.61 vs 0.55, respectively). The 
area under the curve for the impaired glucose tool in adolescents is less than what has been found in adults (0.61 vs 
0.74-0.80). One reason this tool may not be as predictive in adolescents is that other variables, such as lipid aerobic 
fitness, physical activity levels, or puberty and sexual development, may also be important (19-23). Unfortunately, 
many of these variables were not consistently available in the NHANES data sets for significance testing and inclusion 
in the model. Also, the goal of this study was to develop a tool for assessing risk of impaired fasting glucose that uses 
noninvasive variables easily measured in nonmedical settings. Although some lipid measures are available in 
NHANES, they were excluded from inclusion in the model in order to investigate its applicability for community use. 
Beyond community use, the parameters necessary for calculating the TAG-IT-A score may also be routinely available in 
electronic medical records that could be programmed to automatically calculate this score for appropriate patients.
A logical question is what TAG-IT-A score public health or medical practitioners should use to determine if an 
adolescent needs further screening. If a score of 3 is used, then sensitivity is 50%, but sensitivity improves with higher 
criteria. The economic costs of additional tests need to be considered. Furthermore, health care practitioners need to 
decide if they want to maximize the number of cases identified correctly (sensitivity); if so, a value of 5 or higher might 
be used. In contrast, if health care practitioners are more concerned about minimizing the number of false positives, 
then a lower score with a higher specificity could be used (eg, 3 or higher, 65% specificity).
Few children and adolescents have fasting glucose values above 100 mg/dL (13,23,24). For this reason, using fasting 
glucose measurements to screen the entire population of adolescents is not recommended. New tools are needed to 
help identify at-risk adolescents who may benefit from additional testing to detect abnormal fasting glucose 
concentrations. Community-based screening of adolescents using the TAG-IT-A tool instead of BMI alone may provide 
a feasible and somewhat more sensitive way of identifying adolescents at increased risk of glucose impairment and in 
need of further evaluation or interventions. Having easily assessed measures (eg, heart rate and blood pressure) that 
are related to illness and death in adults (17) suggests that similar measures may indicate health concerns in 
adolescents as well.
The limitations of this study include the cross-sectional design of NHANES; adolescents who have fasting glucose 
values of 100 mg/dL or higher may not go on to develop type 2 diabetes. Nguyen et al (19), however, reported that even 
children who had normal values but were at the higher end of the normal range had an increased risk for developing 
type 2 diabetes as adults. Based on our findings and those of Nguyen et al (19), it appears that a longitudinal study is 
warranted to evaluate the effectiveness of the TAG-IT-A tool. Finally, we did not perform subgroup analysis by race 
because of the small sample size of those with impaired fasting glucose (only 11% of the total NHANES III adolescent 
sample). Therefore, it is unknown whether the tool performs similarly in different races. Similar sample-size issues 
were observed when sex was explored separately.
The TAG-IT-A tool is a simple measure that uses variables that can be obtained in community settings, and it is 
modestly better than BMI alone in predicting risk for impaired fasting glucose. The usefulness of this screening tool for 
identifying adolescents who have impaired fasting glucose should be further evaluated in community-based settings. 
Longitudinal studies are also needed to determine if adolescents with a high TAG-IT-A score subsequently develop 
type 2 diabetes in adulthood.
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Tables 
 
Table 1. Characteristics Included in Development of TAG-IT-A, NHANES, 
1999-2008
Characteristic Proportion of Weighted Sample, % Number in Weighted Sample (Millions)
Age, y
12-14 41.4 1.2
15-18 58.6 1.7
Race/Ethnicity
Non-Hispanic white 62.7 17.9
Non-Hispanic black 14.4 4.1
Hispanic 16.6 3.1
Other 6.2 1.8
Sex
Female 49.0 14.0
Male 50.9 14.6
Fasting glucose, mg/dL
100-125 15.6 4.5
≥126 0.2 0.5
BMI percentile for age and sex
≤84th (normal) 67.7 19.2
85th-94th (overweight) 14.8 4.2
≥95th (obese) 17.5 4.9
Resting heart rate, beats per minute
<60 7.5 2.2
60-69 23.8 6.8
70-79 30.1 8.6
80-89 23.7 6.8
≥90 15.0 4.3
Hypertension
No 97.2 2.3
Yes 2.8 0.8
Abbreviations: TAG-IT-A, Tool for Assessing Glucose ImpairmenT among Adolescents; NHANES, National Health and 
Nutrition Examination Survey; BMI, body mass index. 
 Based on weighted population estimates derived by using SUDAAN version 9 (Research Triangle Institute, Research 
Triangle Park, North Carolina) and NHANES population weights. 
 Based on Centers for Disease Control and Prevention growth charts (9). 
 Hypertension was defined as ≥95th percentile adjusted for age, sex, and height or physician diagnosed hypertension.
 
a a
b
c
a
b
c
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Table 2. Correlations Among Key Variables for TAG-IT-A
Variable
r (P Value)
Fasting 
Glucose Age Sex
Body Mass 
Index
Resting Heart 
Rate Hypertension
Fasting glucose 1
Age .07 (<.001) 1
Sex .23 (<.001) −.02 (.23) 1
BMI .07 (<.001) .04 (.006) .07 
(<.001)
1
Resting heart 
rate
.03 (.05) −.19 
(<.001)
.23 (.001) .01 (.39) 1
Hypertension .03 (.12) .01 (.56) .02 (.27) .09 (<.001) −.01 (.36) 1
Abbreviation: TAG-IT-A, Tool for Assessing Glucose ImpairmenT among Adolescents. 
 Hypertension was defined as ≥95th percentile adjusted for age, sex, and height or physician diagnosed hypertension.
 
Table 3. Odds Ratios and Scores Associated With the Variables Selected for 
Predicting Elevated Glucose Levels  for TAG-IT-A
Characteristic OR (95% CI) TAG-IT-A Score
Age, y
12-14 1.37 (1.07-1.75) 1
15-18 1 [Reference] 0
Sex
Male 2.87 (2.30-3.58) 3
Female 1 [Reference] 0
BMI, percentile for sex and age
≤84th (normal) 1 [Reference] 0
85th-94th (overweight) 1.07 (0.69-1.65) 0
≥95th (obese) 1.66 (1.08-2.55) 2
Resting heart rate, beats per minute
60 1 [Reference] 0
60-69 1.75 (0.97-3.32) 2
70-79 2.56 (1.44-4.56) 3
80-89 2.83 (1.62-4.95) 3
≥90 3.04 (1.63-5.66) 3
Abbreviations: TAG-IT-A, Tool for Assessing Glucose ImpairmenT among Adolescents; OR, odds ratio; CI, confidence 
interval; BMI, body mass index. 
 Elevated glucose level was defined as ≥100 mg/dL. 
 Based on Centers for Disease Control and Prevention growth charts (9).
 
a
a
b
a
b
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Table 4. Percentage, Sensitivity, and Specificity for Selected Scores of TAG-IT-A
Score (%) Sensitivity, % Specificity, %
≥3 (29) 50.0 65.0
≥4 (12) 60.4 49.5
≥5 (13) 76.2 31.5
≥6 (16) 100 0
≥7 (14) 100 0
Abbreviation: TAG-IT-A, Tool for Assessing Glucose ImpairmenT among Adolescents. 
 Percentages do not total 100% because all possible scores are not listed.
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